SUMMARY Lipofuscin develops in cells when peroxidation damage occurs. Its development in the liver of patients receiving prolonged parenteral nutrition suggests that peroxidation damage by free radicals has occurred. Deficiencies in antioxidants such as vitamin E may be an important contributing factor.
Peroxidation damage by free radicals can cause disease of the liver-for example, carbon tetrachloride poisoning' and alcoholic cirrhosis.2 The pathogenesis of the damage to the liver in patients receiving parenteral nutrition is unknown. Lipofuscin found often in hepatic cells may be an important clue. Lipofuscin, a complex of lipids, proteins, and malonaldehyde, develops when subcellular membranes are damaged by peroxidation of free radicals.1 3 Case report A 930 g girl was born at 27 weeks' gestation after her mother had developed amnionitis. She was electively ventilated and treated for pneumonia with intravenous ampicillin and gentamicin for 14 days. No bacteria were cultured, and on day 10 treatment with intravenous fluorocytosine and amphotericin were started after Candida albicans had been cultured in urine obtained by bladder puncture. Con Electron microscopy showed phagolysosomal structures within the cytoplasm of the Kupffer cells and hepatocytes (Figure (a) and (b) ). These structures, enveloped by a single limiting membrane, contained partly electron dense, and partly electron lucent granular material. Electron lucent vacuoles, well developed in the Kupffer cells, were also present. These I3ysosomal structures are compatible with lipofuscin.
The cholestatic jaundice was as a result of its typical course and exclusion of other causes considered to be related to the parenteral nutrition. The liver dysfunction rapidly resolved when complete nasoduodenal feeding was tolerated after day 100. At 2 years of age the child was growing and developing normally and had no evidence of liver disease.
Discussion
Histochemical and ultrastructural studies have suggested that the granules of pigment seen in the liver after parenteral nutrition are lipofuscin. 4 5 The electron microscopic features we found are further evidence3 to support those finding.
Previously, the accumulation of this pigment in subjects was considered to be a complication of receiving fat emulsions ('intravenous fat pigment').6 As the damage to the liver also occurs when no fat emulsion has been used the presence of lipofuscin has not been linked to the pathogenesis of the disease. When we reviewed previous reports, however, we found that lipofuscin had been found in the liver even when only amino acid and glucose electrolyte mixtures had been infused.4 5 Cohen and Olsen detected lipofuscin in 90% of their babies, though only 35% had received fat emulsion. 4 There is a powerful antioxidant defence system in man-for example, enzymes such as glutathione peroxidase and free radical scavengers such as vitamin E.' Nutritional deficiencies-for example, 
